Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer (Q43733512)

26 November 2017

Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer (English)

1 reference

26 November 2017

Marom EM

1

1 reference

26 November 2017

Aloia TA

2

1 reference

26 November 2017

Moore MB

3

1 reference

26 November 2017

Hara M

4

1 reference

26 November 2017

Herndon JE 2nd

5

1 reference

26 November 2017

Harpole DH Jr

6

1 reference

26 November 2017

Goodman PC

7

1 reference

26 November 2017

Patz EF Jr

8

1 reference

26 November 2017

language of work or name

1 reference

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

33

1 reference

26 November 2017

2-3

1 reference

26 November 2017

99-107

1 reference

PET and [18F]-FDG in oncology: a clinical update

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Atypical manifestations of pulmonary adenoid cystic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Characterization of chest masses by FDG positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Prospective investigation of positron emission tomography in lung nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Staging non-small cell lung cancer with whole-body PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Facilitative glucose transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Positron emission tomography imaging in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900250-6

7 January 2021

10.1016/S0169-5002(00)00250-6

Identifiers

DOI

1 reference

26 November 2017

1 reference